We're short biotech and large pharma: Pro

In this video

Share

We're short biotech and large pharma: Pro

Les Funtleyder, E Squared Capital Management, discusses Trump's drug price plan an its potential impact on insurers.
03:53
Fri, May 11 20183:26 PM EDT